Header Logo

Romain Neugebauer

Concepts (515)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Diabetes Mellitus, Type 2
18
2021
755
2.280
Why?
Hypoglycemic Agents
10
2022
271
2.190
Why?
Humans
114
2024
17762
1.870
Why?
Female
90
2024
12740
1.750
Why?
Models, Statistical
9
2016
178
1.730
Why?
Cardiovascular Diseases
7
2024
599
1.720
Why?
Middle Aged
65
2024
7988
1.600
Why?
Aged
54
2024
6150
1.530
Why?
Keratosis, Actinic
3
2018
5
1.370
Why?
Diabetes Mellitus
10
2020
487
1.340
Why?
Electronic Health Records
10
2022
697
1.340
Why?
Comparative Effectiveness Research
5
2018
66
1.330
Why?
Diabetes, Gestational
4
2022
346
1.300
Why?
Male
65
2024
10106
1.300
Why?
Data Interpretation, Statistical
5
2016
77
1.270
Why?
Propensity Score
5
2022
85
1.250
Why?
Adult
54
2024
7678
1.240
Why?
Medication Adherence
5
2024
245
1.240
Why?
Fluorouracil
2
2018
11
1.220
Why?
Diphosphonates
5
2020
63
1.150
Why?
Cohort Studies
29
2024
2586
1.080
Why?
HIV Infections
8
2024
696
1.080
Why?
Algorithms
5
2021
239
1.070
Why?
Hip Fractures
3
2020
67
1.040
Why?
Risk Factors
24
2024
3356
1.020
Why?
Breast Neoplasms
5
2024
954
1.000
Why?
California
33
2020
2326
0.990
Why?
Tumor Necrosis Factor-alpha
6
2018
27
0.940
Why?
Aged, 80 and over
21
2020
1923
0.940
Why?
Exercise
7
2020
492
0.930
Why?
Outcome Assessment (Health Care)
5
2016
228
0.920
Why?
Insulin
3
2022
206
0.910
Why?
Sarcoma, Kaposi
2
2021
12
0.890
Why?
Osteoporotic Fractures
4
2020
40
0.820
Why?
Acquired Immunodeficiency Syndrome
2
2021
63
0.800
Why?
Neoplasms
4
2024
444
0.800
Why?
Glyburide
1
2022
7
0.790
Why?
Asthma
8
2019
385
0.770
Why?
Treatment Outcome
15
2019
1260
0.760
Why?
Arthritis, Rheumatoid
3
2018
23
0.760
Why?
Femoral Fractures
3
2020
22
0.750
Why?
Health Promotion
6
2017
281
0.740
Why?
Retrospective Studies
19
2022
2461
0.720
Why?
Young Adult
18
2020
2461
0.690
Why?
Insulin, Regular, Human
1
2020
5
0.680
Why?
Diabetic Cardiomyopathies
1
2020
4
0.680
Why?
Skin Neoplasms
2
2018
57
0.680
Why?
Albuminuria
3
2014
38
0.640
Why?
Databases, Factual
6
2016
315
0.640
Why?
Telephone
6
2017
161
0.630
Why?
Carcinoma, Basal Cell
1
2018
24
0.620
Why?
Adolescent
23
2021
3685
0.610
Why?
Carcinoma, Squamous Cell
1
2018
55
0.600
Why?
Aminoquinolines
1
2017
1
0.600
Why?
Patient-Centered Care
2
2015
197
0.590
Why?
Proportional Hazards Models
12
2022
710
0.580
Why?
Inflammatory Bowel Diseases
4
2012
17
0.570
Why?
Data Collection
3
2014
256
0.560
Why?
Confounding Factors (Epidemiology)
6
2016
86
0.540
Why?
Practice Patterns, Physicians'
3
2017
331
0.540
Why?
Exercise Therapy
2
2015
71
0.540
Why?
Body Mass Index
7
2021
964
0.530
Why?
Emergency Service, Hospital
3
2015
368
0.530
Why?
Heart Failure
4
2024
396
0.520
Why?
Myocardial Infarction
2
2020
238
0.520
Why?
Machine Learning
1
2016
46
0.510
Why?
Pregnancy
13
2022
1524
0.510
Why?
Randomized Controlled Trials as Topic
3
2013
328
0.510
Why?
Hospitalization
4
2015
808
0.510
Why?
Quality of Life
3
2016
510
0.490
Why?
Anti-Asthmatic Agents
3
2016
85
0.490
Why?
Bone Density Conservation Agents
3
2020
55
0.490
Why?
Bone Screws
2
2005
2
0.480
Why?
Fracture Fixation, Internal
2
2005
3
0.480
Why?
Dementia
3
2014
112
0.480
Why?
Walking
1
2015
85
0.480
Why?
Inflammation
2
2016
63
0.470
Why?
Incidence
11
2016
1266
0.470
Why?
Blood Glucose
2
2013
343
0.450
Why?
Practice Guidelines as Topic
2
2016
321
0.450
Why?
Infant, Newborn
10
2022
855
0.450
Why?
Osteoporosis
3
2020
75
0.450
Why?
Schizophrenia
4
2008
77
0.450
Why?
Depression
4
2015
505
0.430
Why?
Pulmonary Disease, Chronic Obstructive
1
2015
197
0.430
Why?
Medical Record Linkage
2
2012
38
0.430
Why?
Diabetic Nephropathies
1
2013
26
0.430
Why?
Registries
6
2015
472
0.410
Why?
Patient Compliance
4
2014
300
0.410
Why?
Prenatal Exposure Delayed Effects
5
2008
167
0.400
Why?
Models, Structural
1
2012
2
0.400
Why?
Motor Activity
4
2015
212
0.400
Why?
Drug Therapy, Combination
5
2018
114
0.390
Why?
Medical Records
4
2017
100
0.390
Why?
Outcome and Process Assessment (Health Care)
1
2012
102
0.390
Why?
Pharmaceutical Services
2
2019
34
0.390
Why?
Self Report
3
2015
253
0.370
Why?
Time Factors
10
2020
1093
0.360
Why?
United States
14
2021
4003
0.360
Why?
Delivery of Health Care, Integrated
8
2020
535
0.360
Why?
Population Surveillance
1
2012
264
0.350
Why?
Hypertension, Pregnancy-Induced
2
2022
46
0.350
Why?
Pregnancy Trimester, First
2
2020
40
0.350
Why?
Follow-Up Studies
10
2019
1213
0.340
Why?
Child
13
2016
2491
0.340
Why?
Longitudinal Studies
6
2020
719
0.330
Why?
Prospective Studies
5
2024
1279
0.330
Why?
Obesity
3
2017
842
0.330
Why?
Computer Simulation
3
2014
82
0.320
Why?
Chronic Disease
2
2019
428
0.320
Why?
Anti-HIV Agents
4
2024
155
0.320
Why?
Depressive Disorder
3
2010
222
0.310
Why?
Risk Assessment
5
2020
1101
0.310
Why?
Hypertension
3
2023
504
0.300
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2024
172
0.300
Why?
Observational Studies as Topic
2
2021
47
0.300
Why?
Antirheumatic Agents
1
2018
11
0.300
Why?
Child, Preschool
9
2021
1419
0.300
Why?
Health Personnel
2
2016
125
0.290
Why?
Primary Health Care
3
2015
769
0.290
Why?
Mass Screening
3
2015
677
0.290
Why?
CD4 Lymphocyte Count
4
2021
178
0.290
Why?
Program Evaluation
3
2015
223
0.280
Why?
Leiomyosarcoma
2
2017
2
0.280
Why?
Morcellation
2
2017
2
0.270
Why?
Uterine Neoplasms
2
2017
13
0.270
Why?
Pregnancy Complications
2
2020
199
0.270
Why?
Substance-Related Disorders
2
2013
434
0.270
Why?
Mentoring
2
2017
26
0.270
Why?
Lupus Erythematosus, Systemic
1
2016
7
0.270
Why?
Postal Service
2
2020
73
0.270
Why?
Physical Conditioning, Human
1
2016
1
0.270
Why?
Infection
1
2016
17
0.270
Why?
Antimalarials
1
2016
14
0.270
Why?
Glucocorticoids
1
2016
20
0.270
Why?
Clinical Laboratory Techniques
1
2016
10
0.260
Why?
Sports
1
2016
21
0.260
Why?
Quality Improvement
2
2015
194
0.260
Why?
Bone Density
1
2016
92
0.260
Why?
Endophthalmitis
1
2015
1
0.260
Why?
Eye Infections, Bacterial
1
2015
1
0.260
Why?
Phacoemulsification
1
2015
3
0.260
Why?
Bone Transplantation
1
2005
1
0.260
Why?
Bone Substitutes
1
2005
1
0.260
Why?
Patient Education as Topic
2
2015
212
0.260
Why?
Likelihood Functions
3
2021
45
0.250
Why?
Bone Nails
1
2005
1
0.250
Why?
Bone Plates
1
2005
1
0.250
Why?
Antibiotic Prophylaxis
1
2015
14
0.250
Why?
Ethnic Groups
2
2016
485
0.250
Why?
Risk Reduction Behavior
1
2016
108
0.250
Why?
Seizures
1
2015
29
0.250
Why?
Administration, Topical
3
2017
5
0.250
Why?
Intellectual Disability
1
2015
27
0.250
Why?
Drug-Related Side Effects and Adverse Reactions
1
2016
107
0.240
Why?
Antibodies, Monoclonal, Humanized
2
2012
24
0.240
Why?
Translational Medical Research
1
2015
35
0.240
Why?
Education, Medical, Continuing
1
2015
30
0.240
Why?
Antibodies, Monoclonal
2
2012
25
0.240
Why?
Disease Management
3
2015
135
0.240
Why?
Spatial Analysis
1
2014
11
0.240
Why?
Prediabetic State
2
2015
56
0.240
Why?
Data Accuracy
1
2015
27
0.240
Why?
Regression Analysis
5
2018
300
0.240
Why?
Risk Adjustment
1
2014
24
0.240
Why?
Viral Load
4
2020
135
0.240
Why?
Cardiovascular Agents
1
2024
24
0.230
Why?
Socioeconomic Factors
6
2016
630
0.230
Why?
Insurance, Pharmaceutical Services
1
2014
25
0.230
Why?
Reverse Transcriptase Inhibitors
1
2024
24
0.230
Why?
Occupational Health Services
2
2015
15
0.230
Why?
Alcoholism
2
2015
348
0.230
Why?
Infant
8
2022
1192
0.230
Why?
HIV
2
2021
26
0.230
Why?
Selection Bias
2
2014
19
0.230
Why?
Air Pollutants
4
2010
52
0.230
Why?
Managed Care Programs
4
2012
325
0.230
Why?
Sacrum
1
2004
1
0.230
Why?
Health Policy
1
2015
123
0.230
Why?
Pelvic Bones
1
2004
5
0.230
Why?
Spinal Fractures
1
2004
12
0.230
Why?
Diabetic Retinopathy
1
2014
18
0.220
Why?
Pregnancy Outcome
2
2022
156
0.220
Why?
Patient Acceptance of Health Care
2
2015
390
0.220
Why?
Metformin
2
2015
57
0.220
Why?
Anti-Bacterial Agents
1
2015
141
0.220
Why?
Diet
1
2016
365
0.220
Why?
Causality
2
2021
40
0.220
Why?
Orbit
1
2013
1
0.220
Why?
Orbital Diseases
1
2013
1
0.220
Why?
Decompression, Surgical
1
2013
1
0.220
Why?
Thyroid Gland
1
2013
4
0.220
Why?
Disease Progression
2
2015
264
0.220
Why?
Parents
1
2016
296
0.220
Why?
Colorectal Neoplasms
2
2016
615
0.220
Why?
Logistic Models
7
2015
927
0.210
Why?
Lung Diseases, Interstitial
1
2013
5
0.210
Why?
Renal Insufficiency, Chronic
1
2015
179
0.210
Why?
Crohn Disease
2
2011
14
0.210
Why?
Preventive Health Services
1
2014
160
0.210
Why?
Self-Help Groups
1
2013
30
0.210
Why?
Survival Analysis
3
2013
215
0.210
Why?
HIV Protease Inhibitors
2
2024
16
0.200
Why?
Residence Characteristics
1
2014
250
0.200
Why?
Labetalol
1
2022
9
0.200
Why?
Infant, Newborn, Diseases
1
2022
34
0.200
Why?
Azathioprine
1
2011
1
0.200
Why?
Mercaptopurine
1
2011
1
0.200
Why?
Lymphoma
1
2011
6
0.190
Why?
Insulin, Short-Acting
1
2021
3
0.190
Why?
Splenic Neoplasms
1
2011
1
0.190
Why?
Lymphoma, T-Cell, Peripheral
1
2011
1
0.190
Why?
Postoperative Complications
3
2017
102
0.190
Why?
Brain Injuries
1
2011
14
0.190
Why?
Glycated Hemoglobin A
3
2021
216
0.190
Why?
Insulin, Long-Acting
1
2021
11
0.190
Why?
Appointments and Schedules
1
2011
26
0.190
Why?
Patient Participation
3
2016
134
0.190
Why?
Ozone
3
2012
11
0.190
Why?
Referral and Consultation
2
2015
169
0.190
Why?
Adolescent Behavior
1
2013
127
0.190
Why?
Liver Neoplasms
1
2011
40
0.180
Why?
Time
1
2020
20
0.180
Why?
Sex Factors
4
2015
644
0.180
Why?
RNA, Viral
2
2017
64
0.180
Why?
Pharmacy
1
2020
12
0.180
Why?
Adenocarcinoma
1
2012
172
0.180
Why?
Premature Birth
1
2022
137
0.180
Why?
Hysterectomy
2
2017
29
0.170
Why?
Prenatal Care
2
2020
129
0.170
Why?
Surveys and Questionnaires
6
2016
1321
0.170
Why?
Biological Products
2
2018
4
0.170
Why?
Anus Neoplasms
1
2020
26
0.170
Why?
Asian Americans
2
2016
176
0.170
Why?
Pregnancy Complications, Cardiovascular
1
2020
27
0.170
Why?
Mental Disorders
1
2013
280
0.170
Why?
Colitis, Ulcerative
1
2009
9
0.160
Why?
Adrenal Cortex Hormones
3
2016
68
0.160
Why?
Probability
2
2014
79
0.160
Why?
Administration, Cutaneous
1
2018
16
0.160
Why?
Keratinocytes
1
2018
4
0.160
Why?
Intention to Treat Analysis
1
2018
20
0.160
Why?
Adaptation, Psychological
1
2009
77
0.160
Why?
Anemia, Iron-Deficiency
1
2008
7
0.160
Why?
Age Factors
5
2015
918
0.150
Why?
Autoimmune Diseases
2
2012
20
0.150
Why?
CD4-Positive T-Lymphocytes
1
2017
13
0.140
Why?
Salvage Therapy
1
2007
17
0.140
Why?
Uterine Diseases
1
2017
5
0.140
Why?
Numerical Analysis, Computer-Assisted
1
2007
2
0.140
Why?
Dermatologic Agents
1
2017
1
0.140
Why?
HIV-1
1
2007
70
0.140
Why?
Geriatric Assessment
1
2007
39
0.140
Why?
Cross-Sectional Studies
5
2014
1330
0.140
Why?
Hispanic Americans
2
2014
404
0.140
Why?
Homocysteine
1
2007
13
0.140
Why?
Neoplasm Recurrence, Local
2
2017
246
0.140
Why?
Health Maintenance Organizations
3
2013
417
0.140
Why?
Antihypertensive Agents
3
2022
161
0.140
Why?
Weight Loss
2
2017
305
0.140
Why?
Stroke
1
2020
315
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2017
46
0.140
Why?
Psychometrics
1
2007
121
0.140
Why?
Epidemiologic Methods
2
2005
81
0.140
Why?
Health Surveys
2
2015
260
0.140
Why?
Community Health Services
1
2017
83
0.130
Why?
Cognition
1
2007
83
0.130
Why?
Motivational Interviewing
1
2016
33
0.130
Why?
Dideoxynucleosides
1
2016
8
0.130
Why?
African Americans
2
2014
472
0.130
Why?
Comorbidity
3
2015
597
0.130
Why?
Diabetic Neuropathies
1
2016
13
0.130
Why?
Neoplasms, Unknown Primary
1
2016
1
0.130
Why?
Patient Reported Outcome Measures
1
2016
48
0.130
Why?
Mass Media
1
2015
17
0.130
Why?
Leiomyoma
1
2016
13
0.130
Why?
Research Design
5
2015
376
0.130
Why?
Spirometry
1
2015
65
0.130
Why?
Leisure Activities
1
2005
31
0.120
Why?
Self Efficacy
1
2015
68
0.120
Why?
Risk
3
2016
517
0.120
Why?
Life Style
2
2015
333
0.120
Why?
Electronic Mail
1
2015
51
0.120
Why?
Health Status
2
2005
298
0.120
Why?
Leukotriene Antagonists
2
2016
12
0.120
Why?
Body Composition
1
2005
83
0.120
Why?
Health Benefit Plans, Employee
1
2015
20
0.120
Why?
Activities of Daily Living
1
2005
85
0.120
Why?
Mastectomy
1
2005
36
0.120
Why?
Biostatistics
1
2014
10
0.120
Why?
Fracture Healing
2
2005
2
0.120
Why?
Smoking Cessation
1
2016
193
0.120
Why?
Neoplasms, Second Primary
1
2005
29
0.120
Why?
International Classification of Diseases
3
2011
85
0.120
Why?
Motivation
1
2015
131
0.120
Why?
Epidemiologic Studies
2
2012
29
0.120
Why?
Multicenter Studies as Topic
1
2014
86
0.120
Why?
Maternal-Fetal Exchange
2
2008
13
0.110
Why?
Aging
1
2005
162
0.110
Why?
Patient Satisfaction
2
2013
212
0.110
Why?
Achilles Tendon
1
1994
2
0.110
Why?
Tendon Injuries
1
1994
2
0.110
Why?
Bias
4
2022
102
0.110
Why?
Health Systems Plans
1
2013
4
0.110
Why?
Social Support
1
2015
206
0.110
Why?
Vital Signs
1
2013
13
0.110
Why?
Early Medical Intervention
1
2013
10
0.110
Why?
Continental Population Groups
1
2016
302
0.110
Why?
Sulfonylurea Compounds
1
2013
25
0.110
Why?
Survival Rate
3
2016
260
0.110
Why?
Multivariate Analysis
3
2015
568
0.110
Why?
Reproducibility of Results
3
2015
381
0.110
Why?
Employee Incentive Plans
1
2013
4
0.110
Why?
Office Visits
1
2013
80
0.100
Why?
Glomerular Filtration Rate
1
2013
153
0.100
Why?
User-Computer Interface
1
2012
26
0.100
Why?
Sensitivity and Specificity
3
2007
304
0.100
Why?
Adalimumab
2
2012
5
0.100
Why?
Infliximab
2
2012
7
0.100
Why?
Age of Onset
1
2012
79
0.100
Why?
Absorptiometry, Photon
2
2016
50
0.100
Why?
Mohs Surgery
1
2011
1
0.100
Why?
Anti-Inflammatory Agents
2
2012
25
0.100
Why?
Poisson Distribution
2
2012
88
0.100
Why?
Dose-Response Relationship, Drug
1
2012
129
0.100
Why?
Combined Modality Therapy
3
2009
145
0.100
Why?
Air Pollution
2
2012
42
0.100
Why?
Environmental Exposure
2
2010
117
0.090
Why?
Drug Utilization
2
2015
128
0.090
Why?
Statistics as Topic
1
2011
64
0.090
Why?
Health Behavior
1
2013
360
0.090
Why?
Immunosuppressive Agents
2
2012
20
0.090
Why?
HIV Seropositivity
1
1990
31
0.090
Why?
Maternal Welfare
1
2000
14
0.090
Why?
Heart Diseases
1
2010
77
0.080
Why?
Odds Ratio
2
2015
671
0.080
Why?
Postoperative Care
2
2013
20
0.080
Why?
Infant, Small for Gestational Age
2
2020
57
0.080
Why?
Epilepsy
1
1989
13
0.080
Why?
Environmental Pollution
1
2008
4
0.080
Why?
Stochastic Processes
2
2021
2
0.080
Why?
Canada
2
2020
66
0.080
Why?
Suicide
1
1990
124
0.080
Why?
Drug Prescriptions
2
2020
151
0.080
Why?
Twins
1
1998
12
0.080
Why?
Mental Recall
1
1998
31
0.080
Why?
Lung
1
2008
62
0.070
Why?
Methotrexate
1
2018
6
0.070
Why?
Administration, Oral
2
2020
85
0.070
Why?
Terminally Ill
1
2007
8
0.070
Why?
Educational Status
1
1998
200
0.070
Why?
Social Class
1
1998
121
0.070
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2018
65
0.070
Why?
Case-Control Studies
2
2013
1120
0.070
Why?
Predictive Value of Tests
2
2009
354
0.070
Why?
Ovarian Neoplasms
1
2007
49
0.070
Why?
Disease-Free Survival
2
2017
57
0.070
Why?
Reference Values
1
2016
92
0.070
Why?
Interleukins
1
2016
2
0.070
Why?
Health Status Disparities
1
2008
146
0.070
Why?
Lisinopril
1
2016
5
0.070
Why?
International Normalized Ratio
1
2016
22
0.070
Why?
Adrenergic beta-Agonists
1
2016
33
0.070
Why?
China
1
2016
131
0.070
Why?
Glucose
1
2016
30
0.070
Why?
Creatinine
1
2016
65
0.070
Why?
Severity of Illness Index
2
2016
455
0.060
Why?
Inservice Training
1
2015
14
0.060
Why?
Injections, Intraocular
1
2015
1
0.060
Why?
C-Reactive Protein
1
2016
59
0.060
Why?
Aminoglycosides
1
2015
3
0.060
Why?
Intraoperative Complications
1
2015
5
0.060
Why?
Osteogenesis
1
2005
2
0.060
Why?
Fluoroquinolones
1
2015
7
0.060
Why?
Ankle
1
2005
2
0.060
Why?
Foot
1
2005
3
0.060
Why?
Outpatients
2
2019
110
0.060
Why?
Precipitating Factors
1
2015
2
0.060
Why?
Cephalosporins
1
2015
8
0.060
Why?
Antipsychotic Agents
1
2016
49
0.060
Why?
Diabetes Complications
2
2021
114
0.060
Why?
Peak Expiratory Flow Rate
1
2005
12
0.060
Why?
Warfarin
1
2016
74
0.060
Why?
Leadership
1
2015
39
0.060
Why?
Hypolipidemic Agents
1
2015
40
0.060
Why?
Biomarkers
1
2016
303
0.060
Why?
Feeding Behavior
1
2016
166
0.060
Why?
Postmenopause
1
2016
242
0.060
Why?
Behavior Control
1
2014
4
0.060
Why?
Length of Stay
1
2005
181
0.060
Why?
Cluster Analysis
1
2014
90
0.060
Why?
Physicians
1
2015
137
0.060
Why?
Ilium
1
2004
1
0.060
Why?
Equipment Design
1
2004
8
0.060
Why?
Deductibles and Coinsurance
1
2014
30
0.060
Why?
Radiography
1
2004
39
0.060
Why?
Psychiatric Status Rating Scales
1
2014
125
0.050
Why?
Preoperative Care
1
2013
19
0.050
Why?
Aromatase Inhibitors
1
2023
32
0.050
Why?
Diagnosis, Dual (Psychiatry)
1
2013
28
0.050
Why?
Tamoxifen
1
2023
56
0.050
Why?
Receptors, Tumor Necrosis Factor
1
2012
4
0.050
Why?
Etanercept
1
2012
4
0.050
Why?
Pharmacoepidemiology
1
2022
18
0.050
Why?
Overweight
2
2016
269
0.050
Why?
Antineoplastic Agents, Hormonal
1
2023
63
0.050
Why?
Immunoglobulin G
1
2012
29
0.050
Why?
Methyldopa
1
2022
6
0.050
Why?
Nifedipine
1
2022
7
0.050
Why?
Trastuzumab
1
2022
14
0.050
Why?
Colectomy
1
2012
27
0.050
Why?
Anthracyclines
1
2022
14
0.050
Why?
Mortality
1
2012
118
0.050
Why?
Recovery of Function
1
2011
27
0.050
Why?
Boston
1
2021
35
0.050
Why?
Femur
1
2020
10
0.050
Why?
Patient Selection
2
2008
190
0.040
Why?
Hawaii
1
2020
44
0.040
Why?
Immunosuppression
1
2020
7
0.040
Why?
Viremia
1
2020
9
0.040
Why?
Ideal Body Weight
1
2020
10
0.040
Why?
Colonoscopy
1
2012
253
0.040
Why?
Thinness
1
2020
30
0.040
Why?
Proton Pump Inhibitors
1
2020
24
0.040
Why?
Gestational Age
1
2020
111
0.040
Why?
Linear Models
2
2011
231
0.040
Why?
Digestive System Surgical Procedures
1
2009
6
0.040
Why?
European Continental Ancestry Group
1
2011
529
0.040
Why?
Patient Portals
1
2019
24
0.040
Why?
Hemoglobinometry
1
2008
3
0.040
Why?
Body Weight
1
2020
223
0.040
Why?
Confidence Intervals
1
2009
237
0.040
Why?
Infant, Low Birth Weight
1
2008
35
0.040
Why?
Infant, Premature, Diseases
1
2008
16
0.040
Why?
Depressive Disorder, Major
1
2009
124
0.040
Why?
Drug Evaluation
1
2007
6
0.040
Why?
Drug Resistance, Viral
1
2007
12
0.040
Why?
Deoxycytidine
1
2017
7
0.040
Why?
Taxoids
1
2017
8
0.040
Why?
Minimally Invasive Surgical Procedures
1
2017
6
0.040
Why?
Internet
1
2019
231
0.040
Why?
Chemotherapy, Adjuvant
1
2017
73
0.040
Why?
Ambulatory Care
1
2019
247
0.040
Why?
Cooperative Behavior
1
2007
91
0.040
Why?
Observation
1
2007
23
0.040
Why?
Neuropsychological Tests
1
2007
41
0.040
Why?
Insurance Claim Review
1
2017
61
0.040
Why?
Receptors, N-Methyl-D-Aspartate
1
2007
4
0.030
Why?
Pregnancy Trimester, Third
1
2007
17
0.030
Why?
Clinical Trials as Topic
1
2007
132
0.030
Why?
Antiretroviral Therapy, Highly Active
1
2007
93
0.030
Why?
Child of Impaired Parents
1
2007
33
0.030
Why?
Early Detection of Cancer
1
2012
513
0.030
Why?
Psychotic Disorders
1
2007
44
0.030
Why?
Automation
1
2016
24
0.030
Why?
Health Care Surveys
1
2017
230
0.030
Why?
Uterine Myomectomy
1
2016
1
0.030
Why?
Incidental Findings
1
2016
26
0.030
Why?
Electric Impedance
1
2005
7
0.030
Why?
Kaplan-Meier Estimate
1
2016
129
0.030
Why?
Cause of Death
1
2016
181
0.030
Why?
Glucose Tolerance Test
1
2015
108
0.030
Why?
Anthropometry
1
2005
66
0.030
Why?
Imidazoles
1
2015
4
0.030
Why?
Rosuvastatin Calcium
1
2015
4
0.030
Why?
Morbidity
1
2015
59
0.030
Why?
Colorado
1
2016
164
0.030
Why?
Tetrazoles
1
2015
15
0.030
Why?
Neoplasm Metastasis
1
2005
31
0.030
Why?
Drug Costs
1
2015
34
0.030
Why?
Mastectomy, Segmental
1
2005
20
0.030
Why?
Cost Sharing
1
2015
30
0.030
Why?
Angiotensin Receptor Antagonists
1
2015
53
0.030
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2015
86
0.030
Why?
Prevalence
1
2007
886
0.030
Why?
Casts, Surgical
1
1994
1
0.030
Why?
Shoes
1
1994
1
0.030
Why?
Suture Techniques
1
1994
1
0.030
Why?
Rupture
1
1994
2
0.030
Why?
Fibrin Tissue Adhesive
1
1994
2
0.030
Why?
Insurance, Health
1
2015
183
0.030
Why?
Physical Therapy Modalities
1
1994
3
0.030
Why?
Ambulatory Care Facilities
1
2013
69
0.030
Why?
Models, Organizational
1
2013
55
0.030
Why?
Professional-Patient Relations
1
2013
47
0.030
Why?
Virus Replication
1
2011
12
0.020
Why?
Marital Status
1
2011
21
0.020
Why?
Postoperative Hemorrhage
1
2011
8
0.020
Why?
New Jersey
1
2011
5
0.020
Why?
Tennessee
1
2011
6
0.020
Why?
Pennsylvania
1
2011
25
0.020
Why?
United States Food and Drug Administration
1
2011
34
0.020
Why?
Clinical Trials, Phase IV as Topic
1
2011
3
0.020
Why?
Vulnerable Populations
1
2011
39
0.020
Why?
Medicare
1
2011
205
0.020
Why?
Medicaid
1
2011
190
0.020
Why?
Inhalation Exposure
1
2008
5
0.020
Why?
Skin Tests
1
2008
2
0.020
Why?
Epidemiological Monitoring
1
2008
25
0.020
Why?
Environmental Monitoring
1
2008
26
0.020
Why?
Fathers
1
1998
10
0.020
Why?
Pregnancy Trimesters
1
2008
30
0.020
Why?
Occupations
1
1998
16
0.020
Why?
Models, Theoretical
1
2008
70
0.020
Why?
Maternal Exposure
1
2008
62
0.020
Why?
Delivery of Health Care
1
2011
415
0.020
Why?
Terminal Care
1
2007
41
0.020
Why?
Lymphoma, B-Cell
1
2006
1
0.020
Why?
Gene Expression
1
2006
23
0.020
Why?
Software
1
2006
22
0.020
Why?
Lymphoma, Large B-Cell, Diffuse
1
2006
14
0.020
Why?
Respiratory Sounds
1
2005
12
0.020
Why?
Health Services Accessibility
1
2008
292
0.020
Why?
Quality of Health Care
1
2008
326
0.020
Why?
Health Knowledge, Attitudes, Practice
1
2008
382
0.020
Why?
Concepts (515)
Explore
_
Co-Authors (51)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_
-->

© 2025 Kaiser Permanente